Retour aux projets

12948.1;9 PFLS-LS

Synthetic Biology for the Discovery of Novel 11 B-HSD Inhibitors

Résumé

Synthetic Biology for the Discovery of Novel 11 B-HSD Inhibitors

Textes supplémentaires

Abstract

The enzyme 11â-hydroxysteroid dehydrogenase type 1 (11â-HSD1) acts as a cellular switch to mediate glucocorticoid action. Excessive cortisol production through 11â-HSD1 has been implicated in several diseases like metabolic syndrome, type II diabetes, obesity and skin aging. This project aims at the discovery of novel specific inhibitors of 11â-HSD1 using Evolva¿s Synthetic Biology Technology Platform. Alongside we will improve this technology in several aspects that will allow us to rebuild unknown biosynthetic pathways in yeast and efficiently identify and produce bioactive compounds for the healthcare industry.

Participants

Eric Kübler

Kontaktperson

eric.kuebler@fhnw.ch

Fachhochschule Nordwestschweiz Eric Kübler Gründenstr. 40 4132 Muttenz BL CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2012-01-31
Date de fin
2015-11-30
Coûts totaux approuvés
CHF 377920.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%